Table 1.

Summary of clinicopathologic data of patients with ovarian cancer

CharacteristicsPatients (107)
No. (%)
Tumor cell type
    Serous62 (57.9)
    Endometrioid14 (13.1)
    Mixed11 (10.3)
    Clear cell9 (8.4)
    TCC1 (0.9)
    UC8 (7.5)
    MC2 (1.9)
FIGO tumor stage
    I30 (28.0)
    II9 (8.4)
    III63 (58.8)
    IV5 (4.7)
Patient age (y)
    Mean63.5
    Median64.0
    SD11.5
Type of therapy
    Cisplatin + taxol62 (57.9)
    Platinum-based chemotherapy without taxol21 (29.7)
    Other2 (1.9)
    None (FIGO Ia)5 (4.7)
    Refused/dead13 (12.1)
    Missing4 (3.7)
Residual tumor
    None39 (41.0)
    <1 cm22 (23.1)
    >1 cm34 (35.8)
  • Abbreviations: TCC, transitional cell carcinoma of the ovary; UC, undifferentiated carcinoma of the ovary; MC, mucinous carcinoma of the ovary.